Search research articles
Contact Us
Filters
Showing results (11-20 of 73) with videos related to
Page
of 8
Sort By:
Molecular Cancer
|
November 7, 2021
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer
Gongmin Zhu, Lijiao Pei, Hongwei Xia, et al.
International Journal of Oncology
|
October 5, 2022
[Corrigendum] miR‑200b/c targets the expression of RhoE and inhibits the proliferation and invasion of non‑small cell lung cancer cells
Qiulin Tang, Mingxing Li, Liang Chen, et al.
Frontiers in Oncology
|
September 12, 2022
Targeting the key cholesterol biosynthesis enzyme squalene monooxygenasefor cancer therapy
Yuheng Zou, Hongying Zhang, Feng Bi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 24, 2021
PKM2 compensates for proteasome dysfunction by mediating the formation of the CHIP-HSP70-BAG3 complex and the aggregation of ubiquitinated proteins
Chenliang Zhang, Qiulin Tang, Hongwei Xia, et al.
Cell Death Discovery
|
August 8, 2021
Ursodeoxycholic acid suppresses the malignant progression of colorectal cancer through TGR5-YAP axis
Huan Zhang, Huanji Xu, Chenliang Zhang, et al.
Medical Physics
|
December 24, 2005
Exact fan-beam and 4pi-acquisition cone-beam SPECT algorithms with uniform attenuation correction
Qiulin Tang, Gengsheng L Zeng, Jiansheng Wu, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer
|
July 23, 2020
Cholesterol metabolism: New functions and therapeutic approaches in cancer
Huanji Xu, Sheng Zhou, Qiulin Tang, et al.
Molecular Cancer
|
October 22, 2025
Targeting proteostasis for cancer therapy: current advances, challenges, and future perspectives
Chenliang Zhang, Jielang Li, Qiulin Tang, et al.
Molecular Cancer Therapeutics
|
September 27, 2019
Dipyridamole Enhances the Cytotoxicities of Trametinib against Colon Cancer Cells through Combined Targeting of HMGCS1 and MEK Pathway
Sheng Zhou, Huanji Xu, Qiulin Tang, et al.
Cancer Letters
|
November 16, 2018
Zoledronic acid enhances the efficacy of the MEK inhibitor trametinib in KRAS mutant cancers
Xinyu Dai, Hongwei Xia, Sheng Zhou, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 73) with videos related to
Sort By:
Page
of 8
Molecular Cancer
|
November 7, 2021
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer
Gongmin Zhu, Lijiao Pei, Hongwei Xia, et al.
International Journal of Oncology
|
October 5, 2022
[Corrigendum] miR‑200b/c targets the expression of RhoE and inhibits the proliferation and invasion of non‑small cell lung cancer cells
Qiulin Tang, Mingxing Li, Liang Chen, et al.
Frontiers in Oncology
|
September 12, 2022
Targeting the key cholesterol biosynthesis enzyme squalene monooxygenasefor cancer therapy
Yuheng Zou, Hongying Zhang, Feng Bi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 24, 2021
PKM2 compensates for proteasome dysfunction by mediating the formation of the CHIP-HSP70-BAG3 complex and the aggregation of ubiquitinated proteins
Chenliang Zhang, Qiulin Tang, Hongwei Xia, et al.
Cell Death Discovery
|
August 8, 2021
Ursodeoxycholic acid suppresses the malignant progression of colorectal cancer through TGR5-YAP axis
Huan Zhang, Huanji Xu, Chenliang Zhang, et al.
Medical Physics
|
December 24, 2005
Exact fan-beam and 4pi-acquisition cone-beam SPECT algorithms with uniform attenuation correction
Qiulin Tang, Gengsheng L Zeng, Jiansheng Wu, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer
|
July 23, 2020
Cholesterol metabolism: New functions and therapeutic approaches in cancer
Huanji Xu, Sheng Zhou, Qiulin Tang, et al.
Molecular Cancer
|
October 22, 2025
Targeting proteostasis for cancer therapy: current advances, challenges, and future perspectives
Chenliang Zhang, Jielang Li, Qiulin Tang, et al.
Molecular Cancer Therapeutics
|
September 27, 2019
Dipyridamole Enhances the Cytotoxicities of Trametinib against Colon Cancer Cells through Combined Targeting of HMGCS1 and MEK Pathway
Sheng Zhou, Huanji Xu, Qiulin Tang, et al.
Cancer Letters
|
November 16, 2018
Zoledronic acid enhances the efficacy of the MEK inhibitor trametinib in KRAS mutant cancers
Xinyu Dai, Hongwei Xia, Sheng Zhou, et al.
Page
of 8